Developer docs
API playgroundTry for free, no card

Search company profiles

Canary Speech

Full company profile

uuid00004gf

Namestring
Canary Speech
Legal namestring
Canary Speech, Inc.
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Canary Speech, Inc. is a privately held AI health technology company incorporated in Delaware and headquartered in Provo, Utah, that builds vocal biomarker software to detect cognitive and behavioral health conditions from short speech samples. Its platform extracts over 2,500 acoustic, prosodic, and linguistic features (including MFCC, pitch, jitter, shimmer, harmonics-to-noise ratio, filler ratios, and out-of-vocabulary metrics) from as little as 20–40 seconds of conversational speech and applies machine learning models, including deep neural networks and patented paired neural network architectures, to screen for anxiety, depression, mild cognitive impairment, Alzheimer's disease, Huntington's disease, Parkinson's disease, and multiple sclerosis. The product portfolio is organized around a core Wellness API and includes the flagship Canary Ambient™ ambient listening tool (real-time, millisecond processing with reported 98% accuracy), modular condition-specific offerings (Canary Behavioral, Canary Cognitive, Canary Safety, Canary Wellness), Canary Express for rapid developer integration, and consumer-facing iOS and Android apps including a free 45-second voice check-in.

The company sells primarily to enterprise buyers through a multi-channel go-to-market model: direct enterprise sales gated by a "Request a Demo" funnel, an API-first self-serve developer motion, listings on the Microsoft Marketplace (Dragon Copilot, reaching 100,000+ clinicians across 9 countries) and Zoom App Marketplace, an authorized reseller relationship with GlobalMed for U.S. federal healthcare systems, and an embedded integration with Teladoc Health. Revenue derives from subscription/recurring enterprise API and platform licensing, channel and reseller margins, CPT-reimbursable clinical encounters under 13 AAPC-approved codes (ranging $2.33 to $272.62 per patient visit), marketplace transaction fees, and freemium consumer tools that funnel into enterprise offerings. Canary Speech has raised approximately $22.3 million in cumulative disclosed funding, holds a multi-jurisdiction patent portfolio of 25+ granted and pending patents across the U.S., Europe, Japan, and Hong Kong, and is HIPAA-compliant, HITRUST e1 certified, and ISO/IEC 27001:2022 and ISO/IEC 42001:2023 certified — positioning it as a clinically validated, enterprise-grade vendor for voice-based clinical decision support.

Short descriptiontext

Canary Speech builds API-first AI vocal biomarker software that detects cognitive and behavioral health conditions from short speech samples, serving healthcare providers, payers, clinical trials, contact centers, and consumer health through its Wellness API, Canary Ambient ambient listening platform, and Microsoft/Zoom marketplace integrations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersProvo, United States
HQ citystring
Provo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vocal biomarker software, clinical voice analysis, ambient AI healthcare, behavioral health screening, speech AI platform
Industry2 codes
PRIMARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHDAAAFAH
Audio & Speech Analytics (call analytics, QA, insights)
NAICS code1 code
  • Sound Recording Industries5122
Product category
Vocal Biomarker Software / Clinical AI Voice Analysis
Social media profiles2 records
GTM motion5 records

Each record includes

Type, Description, Source

Revenue model6 records
1Enterprise API & Platform Licensing
TypeSubscription Recurring
Description

Recurring revenue from enterprise customers (health systems, payers, contact centers, clinical trials) accessing Canary's vocal biomarker API and platform (Canary Ambient™). Custom/quote-based enterprise contracts.

canaryspeech.com
2CPT Reimbursement-Enabled Clinical Services
TypeSubscription Recurring
Description

Provider-side reimbursable screening encounters under CPT codes 96127, 96146, 96112, 96125 (13 AAPC-approved CPT codes ranging from $2.33 to $272.62 per patient visit), enabling health systems and clinicians to monetize Canary-driven assessments.

canaryspeech.com
3Channel Reseller / Federal Healthcare
TypeLicensing Royalties
Description

Reseller margin from authorized reseller GlobalMed, which distributes Canary Speech technology for deployment across U.S. federal healthcare systems, integrated into GlobalMed's eNcounter® connected care platform.

prweb.com
4Consumer Mobile App (Freemium)
TypeFreemium
Description

Free Canary Speech iOS and Android mobile apps enable self-serve use and brand funnel into API/enterprise offerings. A free 45-second voice-based check-in was launched for consumers.

canaryspeech.com
5Marketplace Transaction Revenue (Microsoft, Zoom)
TypeTransaction Fee
Description

Revenue generated via partner app listings on Microsoft Marketplace (Dragon Copilot) and the Zoom App Marketplace, where clinicians and partner organizations procure Canary Ambient™ through marketplace channels.

digitalhealthwire.com
6Clinical Research & Validation Partnerships
TypeProfessional Services
Description

Revenue from research collaborations with academic and clinical partners (e.g., Intermountain Health MS study, HaloScape Turkish GAD/MDD validation, Mayo Clinic, Beth Israel Deaconess, Harvard, NYU) for IRB-approved studies and population-specific validation.

insider.fitt.co
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details4 tiers
1Canary Mobile App (Free)
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free iOS and Android mobile app; takes less than 20 seconds to analyze voice and produce assessments; serves as a self-serve on-ramp to enterprise solutions.

canaryspeech.com
2Free Consumer Voice Check-In
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free 45-second voice-based check-in tool for consumers to identify early signs of stress, anxiety, and depression.

prnewswire.com
3Canary Express (API)
ModelUsage-basedBilling cadencePay-as-you-go
Notes

"Get started right away with Canary's seamless API technology. Integrate into new and existing applications within hours." Custom/quote-based.

canaryspeech.com
4Enterprise Custom Solutions
ModelSubscriptionBilling cadenceMulti-year contract
Notes

"Build custom solutions for any use case. We'll develop and implement a customized plan, no matter how complex your requirements." Quote-based; priced for health systems, payers, clinical trials, and contact centers.

canaryspeech.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Canary Ambient
Description

API-first ambient listening voice biomarker platform for real-time clinical decision support in healthcare and contact centers.

canaryspeech.com
+5 more records
Core offering1 text field

Canary Speech develops an API-first, AI-driven vocal biomarker platform that analyzes short speech samples (20-40 seconds) to detect cognitive and behavioral health conditions including anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, and Multiple Sclerosis. The flagship product, Canary Ambient™, provides real-time ambient listening during clinical and telehealth conversations to surface decision-support signals related to mood and cognitive status. The platform is sold to enterprise healthcare providers, payers, clinical trials, and contact centers, with extensions into consumer health via mobile apps and partner integrations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 98% accuracy in detecting speech patterns for cognitive and behavioral health conditions (anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, MS)
+6 more records
Product overview1 text field

Canary Speech offers a unified vocal biomarker platform organized as a core API-first foundation with multiple modules and consumer-facing products. At the center is the Wellness API (Canary API), which powers Canary Express for rapid integration as well as the four core clinical modules: Canary Behavioral (for stress, anxiety, depression, and other behavioral conditions), Canary Cognitive (for MCI, Alzheimer's, Huntington's, Parkinson's, and multiple sclerosis), Canary Safety (for workplace aggression detection and clinician burnout prevention, including the Canary Ambient Continuous Monitoring variant), and Canary Wellness (for wellness, mood, energy, and stress monitoring). The flagship product, Canary Ambient™, is the industry's first ambient listening voice biomarker tool, providing real-time clinical decision support during patient-clinician conversations and integrating into partners such as Microsoft Dragon Copilot, Zoom (via the Zoom App Marketplace), Teladoc Health, GlobalMed, HaloScape, and JubileeTV. The consumer-facing Canary Speech Mobile App (iOS & Android) and the Free Voice-Based Check-In (45-second tool) extend Canary's clinically validated voice analysis outside of clinical settings, while Canary Express enables partners and developers to embed vocal biomarker scoring into their own applications within hours.

Product and service3 records
1Canary Ambient™
CategoryAmbient voice biomarker platform
Description

The industry's first ambient listening voice biomarker tool. Canary Ambient objectively detects cognitive and behavioral conditions by passively analyzing patient-clinician conversations in real time, providing decision-support signals related to mood and cognitive status without disrupting clinical workflows.

2Canary Ambient Continuous Monitoring
CategoryWorkplace safety voice analysis
Description

Workplace safety variant of Canary Ambient that analyzes in-room audio in real time to detect verbal aggression, address workplace violence, and prevent clinician burnout in healthcare settings. Integrated into Teladoc Health's platform.

3Canary Wellness API (Canary API)
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership24 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-23
Description

Canary Ambient™ is available on the Zoom App Marketplace, giving clinicians access to real-time vocal biomarker insights during telehealth visits. Analyzes 2,500+ speech features for stress, depression, mood, anxiety, and neurodegenerative changes without disrupting clinical conversations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

Strategic collaboration integrating Canary Speech's vocal biomarker technology into HaloScape's multi-modal health intelligence platform. Adds voice analysis for screening across mood, stress, vocal energy, wellness, and mild cognitive impairment. First IRB-approved clinical study will validate voice biomarkers in Turkish for generalized anxiety disorder and major depressive disorder. Expands Canary's global reach through new languages and populations.

3Ermita Alzheimer's Guatemala Group
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-11
Description

Collaboration to advance Spanish-language vocal biomarkers for Alzheimer's detection; supports validation in new populations and languages.

canaryspeech.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-11
Description

GlobalMed is an authorized reseller of Canary Speech's AI-powered vocal biomarker technology for deployment across U.S. federal healthcare systems. The technology is integrated into GlobalMed's eNcounter® connected care platform, analyzing 2,500+ digital biomarkers to identify patterns associated with stress, depression, mood disorders, Alzheimer's, Huntington's, and Parkinson's.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-05
Description

Canary Speech is a featured partner app on Microsoft Marketplace integrated into Dragon Copilot, the AI clinical assistant used by 100,000+ clinicians across the US, Canada, UK, Ireland, France, Germany, Austria, Belgium, and the Netherlands. Canary Ambient is showcased at HIMSS26 in the Microsoft Booth (#2812). Canary has earned the Microsoft Solutions Partner: Healthcare AI Certified Software designation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-25
Description

First-of-its-kind partnership bringing Canary Speech's vocal biomarker technology into the consumer health market. Voice analysis is integrated into JubileeTV video calls to provide families with non-diagnostic insights into wellness, mood, stress, energy, and cognitive trends for aging loved ones, with privacy safeguards including opt-in consent, no voice storage, and no AI training on data.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

First IRB-approved study using AI voice analysis to identify early indicators of Multiple Sclerosis (MS), led by neurologist Dr. Timothy West. Targets 2.9 million people worldwide affected by MS and aims to develop a non-invasive screening tool.

Strategic tierCoreTypeOthersAnnounced on2026-02-09
Description

Canary Speech joined CHAI to advance responsible AI in healthcare, aligning with national recommendations for trustworthy healthcare AI. Active participation in CHAI workgroups such as Ambient AI and Chatbot initiatives; published CHAI Behavioral Health Applied Model Card.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-10-15
Description

Canary Ambient™ Continuous Monitoring is being integrated into Teladoc Health's platform to enhance workplace safety for hospital staff through real-time detection of verbal aggression, addressing workplace violence in healthcare settings.

10NYU (New York University)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

NYU is an esteemed research institution studying how AI voice biomarkers can help gauge pain in patients, in partnership with Canary Speech.

canaryspeech.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-28
Description

Research collaboration with Beth Israel Deaconess Medical Center on advancing Parkinson's detection with vocal biomarkers and speech foundation models.

12National Cerebral and Cardiovascular Center (NCVC), Japan
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Co-authored peer-reviewed study published in The Lancet Regional Health confirming Canary Speech's vocal biomarkers accurately detect mild cognitive impairment; 1,461 older adults studied.

canaryspeech.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-01
Description

Nuvolis Solutions delivers disruptive, high-impact tech solutions to rethink talent development and human management in the age of AI. Together with Canary, transforming how well-being and mental health are assessed in Latin America.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-12-01
Description

Prism Care manages patient health between provider visits by providing a comprehensive set of care services based on individuals' needs, in partnership with Canary Speech.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Mayo Clinic is referenced as a strategic partner supporting Canary's clinical direction, with CMO Dr. Kang Hsu Jr. working closely with Mayo Clinic (alongside Microsoft, Samsung, and LG NOVA) on product development and research.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Samsung is a featured strategic partner; Canary Speech showcases at HIMSS26 in the Samsung Booth (#4335). Samsung appears alongside Microsoft, LG NOVA, and Mayo Clinic as a key ecosystem partner enabling distribution across consumer devices and platforms.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

LG NOVA's goal is to improve quality of life by building new ventures that have a positive impact on the future of people and the planet, including cognitive and behavioral health conditions. LG NOVA also backs ReliefAI Health, a digital health venture Canary is connected to.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-11-01
Description

Microsoft for Healthcare's goal is to accelerate innovation and improve healthcare experiences with AI-powered solutions, actionable insights, and trusted capabilities — directly aligned with Canary's platform.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Life365 provides virtual care, remote patient monitoring, and patient engagement solutions. The partnership integrates their technologies on the Microsoft Cloud for Healthcare platform to deliver scalable, proactive care to large patient populations. Canary CEO Henry O'Connell was part of a Life365 panel on voice/speech technology in January 2023.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Hackensack Meridian Health provides consolidated facility and community reporting for employee health and clinical patient monitoring in partnership with Canary.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Harvard University is prioritizing innovation in healthcare to improve the wellness of physicians, mentors, and patients in partnership with Canary's cutting-edge technology. Beth Israel Deaconess Medical Center (Harvard Medical School's teaching hospital) has collaborated with Canary on Huntington's disease research.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-11-01
Description

The Veteran Business Project promotes military, veterans, and spouses small business ownership opportunities and overall health and wellbeing, partnering with Canary Speech.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-02-10
Description

Strategic partnership with internationally recognized academic institution with a reputation for innovation and research in speech and language.

Strategic tierMinorTypeOthersAnnounced on2020-10-12
Description

Canary Speech was selected for Plug and Play Japan's Selection Day in two programs: IoT as well as Hardtech & Health.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sonde Health develops a vocal biomarker platform for mental and respiratory health conditions using short voice samples. It is the closest direct peer to Canary Speech, competing in vocal biomarker analysis for behavioral and cognitive health with API-first delivery to enterprise health and wellness customers.

TypeDirect peer
Description

Ellipsis Health applies machine learning to vocal biomarkers to detect anxiety and depression, primarily for health systems and payers. It is a direct peer in the vocal biomarker-for-mental-health space, sharing target buyers (health plans, providers) and an evidence-led, API-integrated model.

TypeDirect peer
Description

Winterlight Labs analyzes speech and language to detect and monitor cognitive and mental health conditions, with a focus on clinical trials and CNS drug development. It is a direct peer in the vocal biomarker-for-cognitive-health segment, sharing pharmaceutical trial customers and academic validation partners.

4Kintsugi
TypeDirect peer
Description

Kintsugi uses voice biomarker technology to detect signs of depression and anxiety from short voice clips, sold into health plans, telehealth, and employers. It is a direct peer in API-based vocal mental health screening, overlapping with Canary's behavioral health use case.

TypeDirect peer
Description

Aural Analytics builds clinical-grade speech analytics (Speech Vitals) to assess neurological and respiratory health from voice. It is a direct peer in clinical vocal biomarker analytics for neurological disease, including ALS and Parkinson's, sharing clinical trial and health system buyers with Canary.

TypeDirect peer
Description

Modality.AI provides AI-driven multimodal assessment agents that analyze speech, facial expression, and cognition for clinical trials and telehealth. It is a direct peer in AI-based speech and language assessment for neurological and psychiatric conditions, with overlapping clinical trial customers.

TypeEmerging player
Description

Cogito applies real-time voice AI to analyze customer and patient calls, with deep roots in behavioral analytics for contact centers and behavioral health. It overlaps with Canary's contact center and behavioral health use cases but is more established in customer experience than in clinical vocal biomarker diagnostics.

TypeBroad incumbent
Description

Microsoft's Nuance-built Dragon Copilot is the ambient clinical AI platform in which Canary Ambient is embedded. While it is also a partner, Nuance owns foundational speech recognition IP and broader healthcare AI capabilities that overlap with and could subsume parts of Canary's functionality over time.

TypeBroad incumbent
Description

Amazon (via AWS HealthScribe and Comprehend Medical) provides clinical speech AI services that compete at the ASR and ambient documentation layer underlying Canary's applications. It is a broad incumbent with deep voice AI infrastructure that can replicate or bundle vocal biomarker capabilities.

TypeEmerging player
Description

Hume AI builds a voice and emotion AI platform measuring expression, tone, and well-being from speech, with API access for developers. It is an emerging player overlapping with Canary's vocal wellness and emotion analytics, but with a broader API-first developer focus rather than clinical-validated condition detection.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canary Speech

Vocal Biomarker Software / Clinical AI Voice Analysiscanaryspeech.com

Canary Speech builds API-first AI vocal biomarker software that detects cognitive and behavioral health conditions from short speech samples, serving healthcare providers, payers, clinical trials, contact centers, and consumer health through its Wellness API, Canary Ambient ambient listening platform, and Microsoft/Zoom marketplace integrations.

What Canary Speech does

Canary Speech, Inc. is a privately held AI health technology company incorporated in Delaware and headquartered in Provo, Utah, that builds vocal biomarker software to detect cognitive and behavioral health conditions from short speech samples. Its platform extracts over 2,500 acoustic, prosodic, and linguistic features (including MFCC, pitch, jitter, shimmer, harmonics-to-noise ratio, filler ratios, and out-of-vocabulary metrics) from as little as 20–40 seconds of conversational speech and applies machine learning models, including deep neural networks and patented paired neural network architectures, to screen for anxiety, depression, mild cognitive impairment, Alzheimer's disease, Huntington's disease, Parkinson's disease, and multiple sclerosis. The product portfolio is organized around a core Wellness API and includes the flagship Canary Ambient™ ambient listening tool (real-time, millisecond processing with reported 98% accuracy), modular condition-specific offerings (Canary Behavioral, Canary Cognitive, Canary Safety, Canary Wellness), Canary Express for rapid developer integration, and consumer-facing iOS and Android apps including a free 45-second voice check-in.

The company sells primarily to enterprise buyers through a multi-channel go-to-market model: direct enterprise sales gated by a "Request a Demo" funnel, an API-first self-serve developer motion, listings on the Microsoft Marketplace (Dragon Copilot, reaching 100,000+ clinicians across 9 countries) and Zoom App Marketplace, an authorized reseller relationship with GlobalMed for U.S. federal healthcare systems, and an embedded integration with Teladoc Health. Revenue derives from subscription/recurring enterprise API and platform licensing, channel and reseller margins, CPT-reimbursable clinical encounters under 13 AAPC-approved codes (ranging $2.33 to $272.62 per patient visit), marketplace transaction fees, and freemium consumer tools that funnel into enterprise offerings. Canary Speech has raised approximately $22.3 million in cumulative disclosed funding, holds a multi-jurisdiction patent portfolio of 25+ granted and pending patents across the U.S., Europe, Japan, and Hong Kong, and is HIPAA-compliant, HITRUST e1 certified, and ISO/IEC 27001:2022 and ISO/IEC 42001:2023 certified — positioning it as a clinically validated, enterprise-grade vendor for voice-based clinical decision support.

Canary Speech firmographics

Firmographics
Name
Canary Speech
Legal name
Canary Speech, Inc.
Website
https://canaryspeech.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Canary Speech builds API-first AI vocal biomarker software that detects cognitive and behavioral health conditions from short speech samples, serving healthcare providers, payers, clinical trials, contact centers, and consumer health through its Wellness API, Canary Ambient ambient listening platform, and Microsoft/Zoom marketplace integrations.
Ownership category
akta.pro rank

Canary Speech industry classification

Industry
Product category
Vocal Biomarker Software / Clinical AI Voice Analysis
NAICS
Sound Recording Industries (5122)
akta.pro industry
PRIMARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHDAAAFAH
Audio & Speech Analytics (call analytics, QA, insights)

Keywords

  • Vocal biomarker software
  • Clinical voice analysis
  • Ambient AI healthcare
  • Behavioral health screening
  • Speech AI platform

Where Canary Speech is headquartered

Location

Headquarters

HQ city
Provo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Canary Speech business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise API & Platform Licensing: Recurring revenue from enterprise customers (health systems, payers, contact centers, clinical trials) accessing Canary's vocal biomarker API and platform (Canary Ambient™). Custom/quote-based enterprise contracts.
  2. CPT Reimbursement-Enabled Clinical Services: Provider-side reimbursable screening encounters under CPT codes 96127, 96146, 96112, 96125 (13 AAPC-approved CPT codes ranging from $2.33 to $272.62 per patient visit), enabling health systems and clinicians to monetize Canary-driven assessments.
  3. Channel Reseller / Federal Healthcare: Reseller margin from authorized reseller GlobalMed, which distributes Canary Speech technology for deployment across U.S. federal healthcare systems, integrated into GlobalMed's eNcounter® connected care platform.
  4. Consumer Mobile App (Freemium): Free Canary Speech iOS and Android mobile apps enable self-serve use and brand funnel into API/enterprise offerings. A free 45-second voice-based check-in was launched for consumers.
  5. Marketplace Transaction Revenue (Microsoft, Zoom): Revenue generated via partner app listings on Microsoft Marketplace (Dragon Copilot) and the Zoom App Marketplace, where clinicians and partner organizations procure Canary Ambient™ through marketplace channels.
  6. Clinical Research & Validation Partnerships: Revenue from research collaborations with academic and clinical partners (e.g., Intermountain Health MS study, HaloScape Turkish GAD/MDD validation, Mayo Clinic, Beth Israel Deaconess, Harvard, NYU) for IRB-approved studies and population-specific validation.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goCanary Mobile App (Free)
FreemiumPay-as-you-goFree Consumer Voice Check-In
Usage-basedPay-as-you-goCanary Express (API)
SubscriptionMulti-year contractEnterprise Custom Solutions

Go-to-market motion5 records

Distribution channels7 records

Marketing channels8 records

Canary Speech product offering

Product offering

Core offering

Canary Speech develops an API-first, AI-driven vocal biomarker platform that analyzes short speech samples (20-40 seconds) to detect cognitive and behavioral health conditions including anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, and Multiple Sclerosis. The flagship product, Canary Ambient™, provides real-time ambient listening during clinical and telehealth conversations to surface decision-support signals related to mood and cognitive status. The platform is sold to enterprise healthcare providers, payers, clinical trials, and contact centers, with extensions into consumer health via mobile apps and partner integrations.

Product overview

Canary Speech offers a unified vocal biomarker platform organized as a core API-first foundation with multiple modules and consumer-facing products. At the center is the Wellness API (Canary API), which powers Canary Express for rapid integration as well as the four core clinical modules: Canary Behavioral (for stress, anxiety, depression, and other behavioral conditions), Canary Cognitive (for MCI, Alzheimer's, Huntington's, Parkinson's, and multiple sclerosis), Canary Safety (for workplace aggression detection and clinician burnout prevention, including the Canary Ambient Continuous Monitoring variant), and Canary Wellness (for wellness, mood, energy, and stress monitoring). The flagship product, Canary Ambient™, is the industry's first ambient listening voice biomarker tool, providing real-time clinical decision support during patient-clinician conversations and integrating into partners such as Microsoft Dragon Copilot, Zoom (via the Zoom App Marketplace), Teladoc Health, GlobalMed, HaloScape, and JubileeTV. The consumer-facing Canary Speech Mobile App (iOS & Android) and the Free Voice-Based Check-In (45-second tool) extend Canary's clinically validated voice analysis outside of clinical settings, while Canary Express enables partners and developers to embed vocal biomarker scoring into their own applications within hours.

Differentiator

Problem solved

Functional benefit

Brands

  • Canary Ambient: API-first ambient listening voice biomarker platform for real-time clinical decision support in healthcare and contact centers.
  • Canary Ambient Continuous Monitoring
  • Canary Behavioral
  • Canary Cognitive
  • Canary Safety
  • Canary Wellness

Products and services

  • Canary Ambient™ The industry's first ambient listening voice biomarker tool. Canary Ambient objectively detects cognitive and behavioral conditions by passively analyzing patient-clinician conversations in real time, providing decision-support signals related to mood and cognitive status without disrupting clinical workflows.
  • Canary Ambient Continuous Monitoring Workplace safety variant of Canary Ambient that analyzes in-room audio in real time to detect verbal aggression, address workplace violence, and prevent clinician burnout in healthcare settings. Integrated into Teladoc Health's platform.
  • Canary Wellness API (Canary API)

Quantifiable outcome

  • 98% accuracy in detecting speech patterns for cognitive and behavioral health conditions (anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, MS)
  • +6 more outcomes

Companies that use Canary Speech

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles6 records

Canary Speech technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature7 records

Canary Speech partnerships and signals

Strategic signal

Partnerships

24 partnerships are on record, tiered core, flagship and minor.

  • ZoomcoreTechnology or Integration · 23 June 2026Canary Ambient™ is available on the Zoom App Marketplace, giving clinicians access to real-time vocal biomarker insights during telehealth visits. Analyzes 2,500+ speech features for stress, depression, mood, anxiety, and neurodegenerative changes without disrupting clinical conversations.
  • HaloScapecoreStrategic or Co-development Partner · 27 May 2026Strategic collaboration integrating Canary Speech's vocal biomarker technology into HaloScape's multi-modal health intelligence platform. Adds voice analysis for screening across mood, stress, vocal energy, wellness, and mild cognitive impairment. First IRB-approved clinical study will validate voice biomarkers in Turkish for generalized anxiety disorder and major depressive disorder. Expands Canary's global reach through new languages and populations.
  • Ermita Alzheimer's Guatemala GroupcoreStrategic or Co-development Partner · 11 May 2026Collaboration to advance Spanish-language vocal biomarkers for Alzheimer's detection; supports validation in new populations and languages.
  • GlobalMedcoreChannel Partner/ Reseller/ Distributor · 11 March 2026GlobalMed is an authorized reseller of Canary Speech's AI-powered vocal biomarker technology for deployment across U.S. federal healthcare systems. The technology is integrated into GlobalMed's eNcounter® connected care platform, analyzing 2,500+ digital biomarkers to identify patterns associated with stress, depression, mood disorders, Alzheimer's, Huntington's, and Parkinson's.
  • Microsoft (Dragon Copilot)flagshipStrategic or Co-development Partner · 5 March 2026Canary Speech is a featured partner app on Microsoft Marketplace integrated into Dragon Copilot, the AI clinical assistant used by 100,000+ clinicians across the US, Canada, UK, Ireland, France, Germany, Austria, Belgium, and the Netherlands. Canary Ambient is showcased at HIMSS26 in the Microsoft Booth (#2812). Canary has earned the Microsoft Solutions Partner: Healthcare AI Certified Software designation.
  • JubileeTVcoreStrategic or Co-development Partner · 25 February 2026First-of-its-kind partnership bringing Canary Speech's vocal biomarker technology into the consumer health market. Voice analysis is integrated into JubileeTV video calls to provide families with non-diagnostic insights into wellness, mood, stress, energy, and cognitive trends for aging loved ones, with privacy safeguards including opt-in consent, no voice storage, and no AI training on data.
  • Intermountain Health (Intermountain Ventures)coreStrategic or Co-development Partner · 10 February 2026First IRB-approved study using AI voice analysis to identify early indicators of Multiple Sclerosis (MS), led by neurologist Dr. Timothy West. Targets 2.9 million people worldwide affected by MS and aims to develop a non-invasive screening tool.
  • Coalition for Health AI (CHAI)coreOthers · 9 February 2026Canary Speech joined CHAI to advance responsible AI in healthcare, aligning with national recommendations for trustworthy healthcare AI. Active participation in CHAI workgroups such as Ambient AI and Chatbot initiatives; published CHAI Behavioral Health Applied Model Card.
  • Teladoc HealthcoreOEM/ Whitelabel/ Licensing Partner · 15 October 2025Canary Ambient™ Continuous Monitoring is being integrated into Teladoc Health's platform to enhance workplace safety for hospital staff through real-time detection of verbal aggression, addressing workplace violence in healthcare settings.
  • NYU (New York University)coreStrategic or Co-development Partner · 1 September 2025NYU is an esteemed research institution studying how AI voice biomarkers can help gauge pain in patients, in partnership with Canary Speech.
  • University of Massachusetts Chan Medical SchoolcoreStrategic or Co-development Partner · 28 August 2025Research collaboration with Beth Israel Deaconess Medical Center on advancing Parkinson's detection with vocal biomarkers and speech foundation models.
  • National Cerebral and Cardiovascular Center (NCVC), JapancoreStrategic or Co-development Partner · 24 June 2025Co-authored peer-reviewed study published in The Lancet Regional Health confirming Canary Speech's vocal biomarkers accurately detect mild cognitive impairment; 1,461 older adults studied.
  • Nuvolis SolutionscoreStrategic or Co-development Partner · 1 June 2025Nuvolis Solutions delivers disruptive, high-impact tech solutions to rethink talent development and human management in the age of AI. Together with Canary, transforming how well-being and mental health are assessed in Latin America.
  • Prism CareminorStrategic or Co-development Partner · 1 December 2024Prism Care manages patient health between provider visits by providing a comprehensive set of care services based on individuals' needs, in partnership with Canary Speech.
  • Mayo ClinicflagshipStrategic or Co-development Partner · 1 November 2024Mayo Clinic is referenced as a strategic partner supporting Canary's clinical direction, with CMO Dr. Kang Hsu Jr. working closely with Mayo Clinic (alongside Microsoft, Samsung, and LG NOVA) on product development and research.
  • SamsungflagshipStrategic or Co-development Partner · 1 November 2024Samsung is a featured strategic partner; Canary Speech showcases at HIMSS26 in the Samsung Booth (#4335). Samsung appears alongside Microsoft, LG NOVA, and Mayo Clinic as a key ecosystem partner enabling distribution across consumer devices and platforms.
  • LG NOVAflagshipStrategic or Co-development Partner · 1 November 2024LG NOVA's goal is to improve quality of life by building new ventures that have a positive impact on the future of people and the planet, including cognitive and behavioral health conditions. LG NOVA also backs ReliefAI Health, a digital health venture Canary is connected to.
  • Microsoft for HealthcarecoreTechnology or Integration · 1 November 2024Microsoft for Healthcare's goal is to accelerate innovation and improve healthcare experiences with AI-powered solutions, actionable insights, and trusted capabilities — directly aligned with Canary's platform.
  • Life365coreStrategic or Co-development Partner · 1 November 2024Life365 provides virtual care, remote patient monitoring, and patient engagement solutions. The partnership integrates their technologies on the Microsoft Cloud for Healthcare platform to deliver scalable, proactive care to large patient populations. Canary CEO Henry O'Connell was part of a Life365 panel on voice/speech technology in January 2023.
  • Hackensack Meridian HealthcoreStrategic or Co-development Partner · 1 November 2024Hackensack Meridian Health provides consolidated facility and community reporting for employee health and clinical patient monitoring in partnership with Canary.
  • Harvard UniversityflagshipStrategic or Co-development Partner · 1 November 2024Harvard University is prioritizing innovation in healthcare to improve the wellness of physicians, mentors, and patients in partnership with Canary's cutting-edge technology. Beth Israel Deaconess Medical Center (Harvard Medical School's teaching hospital) has collaborated with Canary on Huntington's disease research.
  • Veteran Business ProjectminorGTM or Marketing Partner · 1 November 2024The Veteran Business Project promotes military, veterans, and spouses small business ownership opportunities and overall health and wellbeing, partnering with Canary Speech.
  • Ulster UniversityminorStrategic or Co-development Partner · 10 February 2022Strategic partnership with internationally recognized academic institution with a reputation for innovation and research in speech and language.
  • Plug and Play JapanminorOthers · 12 October 2020Canary Speech was selected for Plug and Play Japan's Selection Day in two programs: IoT as well as Hardtech & Health.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

Canary Speech competitors and assessment

Company assessment

Direct peers

  • Sonde Health: Sonde Health develops a vocal biomarker platform for mental and respiratory health conditions using short voice samples. It is the closest direct peer to Canary Speech, competing in vocal biomarker analysis for behavioral and cognitive health with API-first delivery to enterprise health and wellness customers.
  • Ellipsis Health: Ellipsis Health applies machine learning to vocal biomarkers to detect anxiety and depression, primarily for health systems and payers. It is a direct peer in the vocal biomarker-for-mental-health space, sharing target buyers (health plans, providers) and an evidence-led, API-integrated model.
  • Winterlight Labs: Winterlight Labs analyzes speech and language to detect and monitor cognitive and mental health conditions, with a focus on clinical trials and CNS drug development. It is a direct peer in the vocal biomarker-for-cognitive-health segment, sharing pharmaceutical trial customers and academic validation partners.
  • Kintsugi: Kintsugi uses voice biomarker technology to detect signs of depression and anxiety from short voice clips, sold into health plans, telehealth, and employers. It is a direct peer in API-based vocal mental health screening, overlapping with Canary's behavioral health use case.
  • Aural Analytics: Aural Analytics builds clinical-grade speech analytics (Speech Vitals) to assess neurological and respiratory health from voice. It is a direct peer in clinical vocal biomarker analytics for neurological disease, including ALS and Parkinson's, sharing clinical trial and health system buyers with Canary.
  • Modality.AI: Modality.AI provides AI-driven multimodal assessment agents that analyze speech, facial expression, and cognition for clinical trials and telehealth. It is a direct peer in AI-based speech and language assessment for neurological and psychiatric conditions, with overlapping clinical trial customers.

Emerging players

  • Cogito (Cogito Corp): Cogito applies real-time voice AI to analyze customer and patient calls, with deep roots in behavioral analytics for contact centers and behavioral health. It overlaps with Canary's contact center and behavioral health use cases but is more established in customer experience than in clinical vocal biomarker diagnostics.
  • Hume AI: Hume AI builds a voice and emotion AI platform measuring expression, tone, and well-being from speech, with API access for developers. It is an emerging player overlapping with Canary's vocal wellness and emotion analytics, but with a broader API-first developer focus rather than clinical-validated condition detection.

Broad incumbents

  • Microsoft (Nuance / Dragon Copilot): Microsoft's Nuance-built Dragon Copilot is the ambient clinical AI platform in which Canary Ambient is embedded. While it is also a partner, Nuance owns foundational speech recognition IP and broader healthcare AI capabilities that overlap with and could subsume parts of Canary's functionality over time.
  • Amazon (AWS HealthScribe / Comprehend Medical): Amazon (via AWS HealthScribe and Comprehend Medical) provides clinical speech AI services that compete at the ASR and ambient documentation layer underlying Canary's applications. It is a broad incumbent with deep voice AI infrastructure that can replicate or bundle vocal biomarker capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Canary Speech social profiles

Digital presence

Canary Speech compliance and trust

Trust signal

Compliance5 records

Canary Speech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canary Speech leadership team

Management profile

Number of profiles

Profiles7 records

Canary Speech funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canary Speech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canary Speech

What does Canary Speech do?

Canary Speech develops an API-first, AI-driven vocal biomarker platform that analyzes short speech samples (20-40 seconds) to detect cognitive and behavioral health conditions including anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, and Multiple Sclerosis. The flagship product, Canary Ambient™, provides real-time ambient listening during clinical and telehealth conversations to surface decision-support signals related to mood and cognitive status. The platform is sold to enterprise healthcare providers, payers, clinical trials, and contact centers, with extensions into consumer health via mobile apps and partner integrations.

Is Canary Speech a public or private company?

Canary Speech is a private company. It is classified as venture growth investor backed and is currently operating.

When was Canary Speech founded?

Canary Speech was founded in 2017. It employs 11 to 50 people.

Where is Canary Speech based?

Canary Speech is headquartered in Provo, United States, in the North America region.

How does Canary Speech make money?

Six revenue lines are on record. Enterprise API & Platform Licensing is the primary driver. The others are CPT Reimbursement-Enabled Clinical Services, channel Reseller / Federal Healthcare, consumer Mobile App (Freemium), marketplace Transaction Revenue (Microsoft, Zoom) and clinical Research & Validation Partnerships.

Who are Canary Speech's main competitors?

Direct peers on record are Sonde Health, Ellipsis Health, Winterlight Labs, Kintsugi, Aural Analytics and Modality.AI. Emerging players are Cogito (Cogito Corp) and Hume AI. Broad incumbents are Microsoft (Nuance / Dragon Copilot) and Amazon (AWS HealthScribe / Comprehend Medical).

Does Canary Speech have an API?

Yes. Canary Speech is built as an API-first platform offering the Wellness API and Canary Express for seamless integration into new and existing applications within hours. The API enables developers to access patented vocal biomarker analysis for clinical decision support, including stress, mood, energy, anxiety, depression, cognitive, and behavioral health assessments. The platform provides HIPAA-compliant, fully anonymous solutions with CIS Control auditing, vulnerability scanning, and cleared API penetration testing. Canary also offers an API-first real-time voice analysis solution (Canary Ambient) for healthcare and contact centers, processing and analyzing clinical conversations within milliseconds. Developer documentation is at canaryspeech.com/docs.

What industry is Canary Speech in?

Canary Speech's product category is Vocal Biomarker Software / Clinical AI Voice Analysis. Its primary akta.pro industry code is HLACAFAD, Behavioral Health & Substance Use Remote Monitoring, with a secondary code of HDAAAFAH, Audio & Speech Analytics (call analytics, QA, insights). Its NAICS code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCanary Speech and VillageFor Partner to Bring Voice-Based Mental Wellness Check-Ins to MothersCanary Speech and VillageFor announced a partnership integrating AI-powered vocal analysis into VillageFor's journaling feature, launching October 1st. The assessment is an add-on to the free My Village app and included in Village Plus, with a #AskHerTwice campaign launching October 10th.PR NewswireCanary Speech Awarded on TIME's List of the World's Top HealthTech Companies 2026 ListCanary Speech was included in TIME's World's Top HealthTech Companies 2026 list, announced September 17, 2026, marking its second recognition. The company's vocal biomarker technology analyzes speech to detect behavioral, cognitive, and neurological conditions. It offers solutions for clinical, wellness, and safety applications.IntelligenthealthNeuroLexIQ and Canary Speech partner to bring AI voice analysis to the personal injury intake process – Intelligent Health.techCanary Speech and NeuroLexIQ announced a strategic partnership to incorporate AI voice analysis for concussion screening into personal injury case intake processes. The integration aims to identify potential brain injuries early, enhancing documentation and validation before symptoms fade.AijournNeuroLexIQ and Canary Speech Partner to Bring AI Voice Analysis to the Personal Injury Intake ProcessCanary Speech and NeuroLexIQ announced a strategic partnership to integrate AI-powered voice biomarker technology into NeuroLexIQ's concussion screening workflow for personal injury cases, enabling objective detection of potential brain injuries during initial client intake calls. The integrated platform will generate a Concussion Probability Report using speech analysis, which can then be validated through qEEG testing to create litigation-ready documentation. A pilot program will launch on July 1, 2026, giving personal injury attorneys early access to the combined voice-and-EEG screening workflow.PR NewswireNeuroLexIQ and Canary Speech Partner to Bring AI Voice Analysis to the Personal Injury Intake ProcessCanary Speech and NeuroLexIQ announced a strategic partnership to integrate AI-powered voice biomarker technology into NeuroLexIQ's personal injury intake process, enabling concussion probability screening during a client's first intake call. The integrated platform analyzes speech patterns to generate a Concussion Probability Report and can flag potential brain injuries before traditional medical exams occur, with a pilot program launching July 1, 2026. The collaboration pairs Canary Speech's vocal analysis with NeuroLexIQ's qEEG validation to create litigation-ready records for personal injury attorneys.TrendHunter.comAI-Powered Health Intelligence Platforms : health intelligence platformHaloScape, an AI-powered health intelligence platform, announced a strategic collaboration with Canary Speech to integrate voice analysis capabilities into its multi-modal ecosystem.TrendHunter.comAI-Powered Health Intelligence PlatformsHaloScape, an AI-powered health intelligence platform, announced a strategic collaboration with Canary Speech to integrate vocal biomarker screening into its multi-modal ecosystem. The integration adds device-free voice analysis capabilities for mood, stress, vocal energy, wellness, and mild cognitive impairment detection to HaloScape's existing daily Halo Score, real-time stress tracking, sleep analysis, and HaloSight clinical decision support tools. Voice-based screening complements traditional wearable and lab data by capturing biological and behavioral patterns through everyday speech during routine interactions and clinical visits.AijournCanary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth VisitCanary Speech has launched its Canary Ambient AI-powered vocal biomarker technology on the Zoom App Marketplace, enabling clinicians to access real-time behavioral and cognitive health insights during telehealth visits. The platform analyzes over 2,500 speech features to detect acoustic and linguistic patterns associated with stress, depression, mood, anxiety, and neurodegenerative changes without disrupting clinical conversations. This integration makes voice-based clinical decision support accessible to the millions of providers already using Zoom for virtual care.PR NewswireCanary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth VisitCanary Speech has made its AI-powered vocal biomarker technology, Canary Ambient™, available on the Zoom App Marketplace, enabling clinicians to access real-time behavioral and cognitive health insights during telehealth visits conducted on Zoom. The technology analyzes more than 2,500 speech features to detect acoustic and linguistic patterns associated with stress, depression, mood, anxiety, and neurodegenerative changes. This integration aims to capture subtle vocal cues during virtual visits that might otherwise be missed, turning routine telehealth conversations into early health indicators.Digital HealthDigital Health Coffee Time Briefing ☕The article reports that numerous digital health companies and organizations are collaborating or achieving milestones, including HaloScape's partnership with Canary Speech, Berkshire Healthcare NHS Foundation Trust's recognition, and Emerald's partnership with Epassi UK. It also highlights innovations such as care sector technology acquisition and early neurodegenerative risk detection studies. The report covers advancements in health tech, NHS digital transformation, and upcoming industry events.